You are here: Industry Insights > vaccine

News List

Emergent Pledges FDA Improvements at Troubled Vaccine Plant firstwordpharma
June 15, 2021
Emergent BioSolutions is promising the FDA a series of fixes in response to an inspection that led to production stopping at the company's Bayview facility in Baltimore, which had been making Johnson & Johnson's COVID-19 vaccine?, reported Bloomberg.
Good News, Bad News From Alzheimer's Vaccine Trial drugs
June 15, 2021
An experimental Alzheimer's vaccine appears to safely clear abnormal tau protein from the brain, but it's not yet clear whether the shot will be able to save brain function.
Italy's AIFA approves using different vaccine for second dose after AstraZeneca jab firstwordpharma
June 15, 2021
Italy's medicine agency AIFA said Italians under the age of 60 who received a first dose of the AstraZeneca COVID-19 vaccine Vaxzevria can be given a different vaccine when they get their second dose, as reported in Yahoo!News.
Judge Dismisses Lawsuit Over Hospital's COVID-19 Vaccine Policy drugs
June 15, 2021
A lawsuit brought by a group of Houston Methodist employees over the hospital's mandatory COVID-19 vaccination policy was dismissed Saturday by a federal judge.
Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously firstwordpharma
June 15, 2021
Novavax, Inc. today announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax, NVX-CoV2373] and an approved influenza vaccine [Seqirus, adjuvanted, trivalent seasonal influenza vaccine.
Novavax COVID-19 Vaccine Shines in Latest Trial drugs
June 15, 2021
Novavax, announced Monday that its two-shot regimen was more than 90 percent effective overall in a trial that unfolded even as more contagious variants emerged.
Pandemic Life Silver Lining: 73% Have Improved Their Self-Care prnewswire
June 15, 2021
Americans admitting to some pandemic life silver linings according to a healthinsurance national survey of 1,000 U.S. adults.
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial prnewswire
June 15, 2021
Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint.
FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older firstwordpharma
June 11, 2021
Pfizer Inc. (NYSE:PFE) announced today that FDA has approved Prevnar 20? (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae serotypes in the vaccine.
Pfizer cuts Norway's COVID-19 vaccine deliveries, rollout delayed firstwordpharma
June 11, 2021
July deliveries of Pfizer’s COVID-19 vaccine to Norway have been cut by 400,000 doses, delaying the country’s vaccine rollout, the company and the Norwegian Institute of Public Health (FHI) said on Thursday, as reported by This is Money.